Cargando…
Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review)
Osteogenic differentiation originating from mesenchymal stem cells (MSCs) requires tight co-ordination of transcriptional factors, signaling pathways and biomechanical cues. Dysregulation of such reciprocal networks may influence the proliferation and apoptosis of MSCs and osteoblasts, thereby impai...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257936/ https://www.ncbi.nlm.nih.gov/pubmed/32494359 http://dx.doi.org/10.3892/br.2020.1305 |
_version_ | 1783540074805198848 |
---|---|
author | Sun, Hong Peng, Guoxuan Wu, Hongbin Liu, Miao Mao, Guping Ning, Xu Yang, Hua Deng, Jin |
author_facet | Sun, Hong Peng, Guoxuan Wu, Hongbin Liu, Miao Mao, Guping Ning, Xu Yang, Hua Deng, Jin |
author_sort | Sun, Hong |
collection | PubMed |
description | Osteogenic differentiation originating from mesenchymal stem cells (MSCs) requires tight co-ordination of transcriptional factors, signaling pathways and biomechanical cues. Dysregulation of such reciprocal networks may influence the proliferation and apoptosis of MSCs and osteoblasts, thereby impairing bone metabolism and homeostasis. An increasing number of studies have shown that long non-coding (lnc)RNAs are involved in osteogenic differentiation and thus serve an important role in the initiation, development, and progression of bone diseases such as tumors, osteoarthritis and osteoporosis. It has been reported that the lncRNA, maternally expressed gene 3 (MEG3), regulates osteogenic differentiation of multiple MSCs and also acts as a critical mediator in the development of bone formation and associated diseases. In the present review, the proposed mechanisms underlying the roles of MEG3 in osteogenic differentiation and its potential effects on bone diseases are discussed. These discussions may help elucidate the roles of MEG3 in osteogenic differentiation and highlight potential biomarkers and therapeutic targets for the treatment of bone diseases. |
format | Online Article Text |
id | pubmed-7257936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-72579362020-06-02 Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review) Sun, Hong Peng, Guoxuan Wu, Hongbin Liu, Miao Mao, Guping Ning, Xu Yang, Hua Deng, Jin Biomed Rep Review Osteogenic differentiation originating from mesenchymal stem cells (MSCs) requires tight co-ordination of transcriptional factors, signaling pathways and biomechanical cues. Dysregulation of such reciprocal networks may influence the proliferation and apoptosis of MSCs and osteoblasts, thereby impairing bone metabolism and homeostasis. An increasing number of studies have shown that long non-coding (lnc)RNAs are involved in osteogenic differentiation and thus serve an important role in the initiation, development, and progression of bone diseases such as tumors, osteoarthritis and osteoporosis. It has been reported that the lncRNA, maternally expressed gene 3 (MEG3), regulates osteogenic differentiation of multiple MSCs and also acts as a critical mediator in the development of bone formation and associated diseases. In the present review, the proposed mechanisms underlying the roles of MEG3 in osteogenic differentiation and its potential effects on bone diseases are discussed. These discussions may help elucidate the roles of MEG3 in osteogenic differentiation and highlight potential biomarkers and therapeutic targets for the treatment of bone diseases. D.A. Spandidos 2020-07 2020-05-15 /pmc/articles/PMC7257936/ /pubmed/32494359 http://dx.doi.org/10.3892/br.2020.1305 Text en Copyright: © Sun et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Review Sun, Hong Peng, Guoxuan Wu, Hongbin Liu, Miao Mao, Guping Ning, Xu Yang, Hua Deng, Jin Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review) |
title | Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review) |
title_full | Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review) |
title_fullStr | Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review) |
title_full_unstemmed | Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review) |
title_short | Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review) |
title_sort | long non-coding rna meg3 is involved in osteogenic differentiation and bone diseases (review) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257936/ https://www.ncbi.nlm.nih.gov/pubmed/32494359 http://dx.doi.org/10.3892/br.2020.1305 |
work_keys_str_mv | AT sunhong longnoncodingrnameg3isinvolvedinosteogenicdifferentiationandbonediseasesreview AT pengguoxuan longnoncodingrnameg3isinvolvedinosteogenicdifferentiationandbonediseasesreview AT wuhongbin longnoncodingrnameg3isinvolvedinosteogenicdifferentiationandbonediseasesreview AT liumiao longnoncodingrnameg3isinvolvedinosteogenicdifferentiationandbonediseasesreview AT maoguping longnoncodingrnameg3isinvolvedinosteogenicdifferentiationandbonediseasesreview AT ningxu longnoncodingrnameg3isinvolvedinosteogenicdifferentiationandbonediseasesreview AT yanghua longnoncodingrnameg3isinvolvedinosteogenicdifferentiationandbonediseasesreview AT dengjin longnoncodingrnameg3isinvolvedinosteogenicdifferentiationandbonediseasesreview |